deeper: m-folfoxiri and cetuximab versus bevacizumab in mcrc
Published 1 year ago • 256 plays • Length 3:01Download video MP4
Download video MP3
Similar videos
-
1:04
deeper: folfoxiri cetuximab or bevacizumab for 1l mcrc
-
2:45
1l folfoxiri plus cetuximab or bevacizumab for ras wild-type mcrc
-
4:25
fire-4.5: folfoxiri plus either bevacizumab or cetuximab in mcrc
-
1:24
fire-4.5: folfoxiri plus either bevacizumab or cetuximab as 1l treatment of braf v600e-mutant mcrc
-
3:15
predictive biomarkers for ras-wt mcrc treated with cetuximab and m-folfoxiri
-
4:28
introduction: bevacizumab versus cetuximab in metastatic colorectal cancer
-
8:22
colorectal trials at wcgic 2023: velo, deeper, improve and avetric
-
3:58
dr. cathy eng on bevacizumab plus folfoxiri for patients with mcrc
-
9:07
tribe-2: folfox or folfiri with bevacizumab in mcrc
-
8:16
beacon crc: first-line bevacizumab in colorectal cancer treatment
-
1:10
dr. chiara cremolini on frontline folfoxiri plus bevacizumab in mcrc
-
4:16
fire-3 study: cetuximab versus bevacizumab in metastatic colorectal cancer
-
2:11
pembrolizumab vs. chemo in first-line mcrc
-
4:56
upfront bevacizumab and cetuximab compared in metastatic colorectal cancer
-
15:09
folfoxiri bevacizumab atezolizumab versus folfoxiri bevacizumab as first-line treatment of...
-
1:05
how will the paradigm trial change the mcrc treatment landscape?
-
2:42
paradigm: panitumumab versus bevacizumab in ras-wt mcrc
-
1:29
dr. cremolini on folfoxiri plus bevacizumab for metastatic colorectal cancer
-
1:08
first-line durvalumab monalizumab in microsatellite-stable crc